565 results on '"Bara C"'
Search Results
2. Everolimus in heart transplantation: an update.
3. Intérêt d’une batterie spécialisée de tests épicutanés dans une cohorte de patients adressés pour hypersensibilité à leur implant orthopédique. Une étude multicentrique du DAG
4. Vascular Remodeling on Intermediate and Long-Term left Ventricular Assist Device (LVAD) Support Under Nonpulsatile versus Pulsatile Blood Flow.
5. Mental health and quality of life in heart transplant candidates: Results of a prospective study
6. Impact du traitement par dupilumab sur les résultats des patch tests
7. Rehabilitation Modulates High-Order Interactions among Large-Scale Brain Networks in Subacute Stroke
8. Investigating the Heartbeat-evoked cortical responses through parametric Time-Varying Information Measures
9. Modalités d’intensification de l’omalizumab dans l’urticaire chronique spontanée, étude multicentrique en vraie vie : analyse intermédiaire
10. Impact du traitement par dupilumab sur les résultats des patch-tests
11. Chronische Abstoßung: Unterschiede und Ähnlichkeiten bei verschiedenen soliden Organtransplantationen
12. Le sérum physiologique n’augmente pas la sensibilité des patch-tests dans les toxidermies
13. Renal Comorbidity After Solid Organ and Stem Cell Transplantation
14. Éruptions eczématiformes chroniques du sujet âgé : quelle imputabilité médicamenteuse ?
15. Intérêt de l’oxybutynine à dose modérée dans l’hyperhidrose étendue
16. Biopsy‐Diagnosed Renal Disease in Patients After Transplantation of Other Organs and Tissues
17. Severe periodontitis attenuated the beneficial effects of physical exercise on biological age: RCI14
18. Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature
19. Observatoire national de la radiothérapie : rapport de l’enquête conduite en 2008 sur l’année 2007
20. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests
21. Lupus attributable to anti-TNF therapy and revealed by interstitial granulomatous dermatitis
22. A MULTI-CENTER, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP PHASE IV TRIAL INVESTIGATING THE OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY OF CNI-REDUCTION OR ELIMINATION WITH EVEROLIMUS IN DE NOVO HEART TRANSPLANT RECIPIENTS: THE MANDELA STUDY DESIGN: P107
23. MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy (CAV).: Abstract# D2348
24. Management of urticaria by French specialists compared to international guideline recommendations
25. Prise en charge des cancers rares : une des missions des pôles régionaux de cancérologie
26. Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
27. Core Signature of Rejection-Specific Cytokines and Chemokines in Heart Biopsies after Transplantation
28. Efficacité et tolérance en vie réelle du baricitinib dans le traitement de la pelade de l’adulte : étude rétrospective multicentrique
29. Réévaluation de l’imputabilité médicamenteuse dans la survenue d’éruptions eczématiformes chroniques du sujet âgé par comparaison aux données du SNDS dans la population générale
30. Should kidney allografts from old donors be allocated only to old recipients?
31. Treatment of ANTI-HLA Donor-Specific Antibodies and Antibody-Mediated Rejection in Heart Transplantation: A Single-Center 3-Year Experience
32. Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis
33. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
34. Chronic Hepatitis E in Heart Transplant Recipients
35. Interleukin 6 (IL-6) and neurotrophin 3 (NT-3) dynamics in patients with ischemic stroke (IS) and COPD: P13-60
36. Hepatitis E Virus Infection in Heart Transplantation Recipients: HEV Seroprevalence, Risk for Chronic Courses and Efficacy of Ribavirin Treatment.: Abstract# 1529 Poster Board #-Session: P91-IV
37. Prolactin - A New Marker for ECMO-Related Mortality.: Abstract# 1242 Poster Board #-Session: P109-III
38. Safety Events of Interest with the De Novo Use of Everolimus in Heart Transplant Recipients: 24-Month Analysis of the A2310 Study.: Abstract# 163
39. CMV INFECTIONS ARE LESS FREQUENT IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING IMMUNOSUPPRESSION WITH EVEROLIMUS PLUS REDUCED CSA COMPARED TO MMF AND STANDARD CSA: 036
40. EFFICACY AND RENAL FUNCTION IN DE NOVO HEART TRANSPLANT RECIPIENTS RECEIVING EVEROLIMUS WITH REDUCED CSA COMPARED TO MMF WITH STANDARD CSA: THE A2310 STUDY: 034
41. Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions
42. DE NOVO EVEROLIMUS- VERSUS MMF-BASED IMMUNOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS: EFFECT ON PROTEINURIA: O-235
43. HLA-C locus and genetic susceptibility to psoriatic arthritis in Romanian population
44. Pemphigoïdes bulleuses associées aux anti-PD-1/PDL-1 : étude nationale de 85 cas
45. Management of urticaria by French specialists compared to international guideline recommendations
46. Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
47. Ex Vivo Organ Perfusion for Heart Procurement in High-Risk Transplantations: A Multicenter Study
48. Heart Preservation with the Organ Care System in Extended Criteria Donors: A Single-Center Experience
49. Ex vivo Heart Perfusion for Heart Transplantation: A Single-Center Update after 5 Years
50. Distribution of HLA-B27 in Romanian spondyloarthritides patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.